Virologic surveillance for wild-type Rubella viruses in the Americas

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 2, 2011, Pages

  Icenogle, Joseph P ^a   Siqueira, Marilda M ^c   Abernathy, Emily S ^a   Lemos, Xenia R ^c   Fasce, Rodrigo A ^d   Torres, Graciela ^d   Reef, Susan E ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d INSTITUTO DE SALUD PÚBLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE; RUBELLA VACCINE;

ARTICLE; ENDEMIC DISEASE; FEVER; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; PRIORITY JOURNAL; RASH; RUBELLA VIRUS; UNITED STATES; VIROLOGY; VIRUS CLASSIFICATION; VIRUS NOMENCLATURE; VIRUS TRANSMISSION; WILD TYPE; DRUG ERUPTION; DRUG FEVER; ENDEMIC SPECIES; EPIDEMIC; INFECTION CONTROL; SPECIES DISTRIBUTION; VIRUS DETECTION; VIRUS GENOME; VIRUS IDENTIFICATION; WESTERN HEMISPHERE;

AMERICAS; GENOTYPE; HUMANS; POPULATION SURVEILLANCE; RUBELLA; RUBELLA VIRUS;

EID: 80053431177     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir431     Document Type: Article

References (35)

1. World Health Organization. Standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses. Wkly Epidemol Rec 1998; 73:165-9.
2. World Health Organization. Update of the nomenclature for describing the genetic characteristics of wild-type measles viruses: new genotypes and reference strains. Wkly Epidemol Rec 2003; 78:229-32.
3. Kew OM, Pallansch MA. The mechanism of poliovirus eradication. In: Semler BL, Wimmer E eds: Molecular biology of picornaviruses. Washington, DC: ASM Press, 2002; 481-91.
4. Bellini WJ, Rota PA. Genetic diversity of wild-type measles viruses: implications for global measles elimination programs. Emerg Infect Dis 1998; 4:29-35. (Pubitemid 28347413)
5. Tipples GA, Gray M, Garbutt M, Rota PA; Canadian Measles Surveillance Program. Genotyping of measles virus in Canada: 1979-2002. J Infect Dis 2004; 189(Suppl 3):S171-76. (Pubitemid 38639586)
6. Centers for Disease Control and Prevention. Measles-United States, January 1-April 25, 2008. Morb Mortal Wkly Rep 2008; 57:494-8.
7. Haddad-Boubaker S, Ben Yahia A, Bahri O, et al. Genetic features of polioviruses isolated in Tunisia, 1991-2006. J Clin Virol 2008; 41:81-6. (Pubitemid 351187889)
8. Kew OM, Morris-Glasgow V, Landaverde M, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002; 296:356-9. (Pubitemid 34303692)
9. Bispo de Filippis AM, Icenogle J, Ruiz Matus C, Andrus JK. Enhanced laboratory surveillance for the elimination of rubella and congenital rubella in the Americas. J Infect Dis 2011; 204(Suppl 2):S652-8.
10. Chen M-H, Icenogle J. Molecular virology of rubella virus. In: Banatvala J, Peckham C, eds: Rubella viruses, perspectives in medical virology. Amsterdam, the Netherlands: Elsevier, 2007; 1-18.
11. Best JM, Banatvala JE. Studies on rubella virus strain variation by kinetic haemagglutination-inhibition tests. J Gen Virol 1970; 9:215-23.
12. Icenogle JP, Frey TK, Abernathy E, Reef SE, Schnurr D, Stewart JA. Genetic analysis of rubella viruses found in the United States between 1966 and 2004: evidence that indigenous rubella viruses have been eliminated. Clin Infect Dis 2006; 43(Suppl 3):S127-32.
13. Frey TK, Abernathy ES. Identification of strain-specific nucleotide sequences in the RA 27/3 rubella virus vaccine. J Infect Dis 1993; 168:854-64. (Pubitemid 23282556)
14. World Health Organization. Standardization of the nomenclature for genetic characterization of wild-type rubella viruses. Wkly Epidemiol Rec 2005; 80:125-32.
15. World Health Organization. Update of standard nomenclature for wild-type rubella viruses. Wkly Epidemol Rec 2007; 82:209-24.
16. World Health Organization. Global distribution of measles and rubella genotypes-update. Wkly Epidemol Rec 2006; 81:49-50.
17. Helfand R, Cabezas C, Abernathy E, et al. Dried blood spots versus sera for detection of rubella virus-specific immunoglobulin M (IgM) and IgG in samples collected during a rubella outbreak in Peru. Clin Vacc Imm 2007; 14:1522-5. (Pubitemid 350304048)
18. Abernathy E, Cabezas C, Sun H, et al. Confirmation of rubella within 4 days of rash onset: comparison of rubella virus RNA detection in oral fluid with immunoglobulin M detection in serum or oral fluid. J Clin Microbiol 2009; 47:182-8.
19. Vijaylakshmi P, Muthukkaruppan VR, Rajasundari A, et al. Evaluation of a commercial rubella IgM assay for use on oral fluid samples for diagnosis and surveillance of congenital rubella syndrome and postnatal rubella. J Clin Virol 2006; 37:265-8. (Pubitemid 44667681)
20. Vyse AJ, Jin L. An RT-PCR assay using oral fluid samples to detect rubella virus genome for epidemiological surveillance. Mol Cell Probes 2002; 16:93-7. (Pubitemid 34712933)
21. Pan American Health Organization. Recommendations of the Technical Advisory Group meeting on vaccine preventable-diseases 2006. http://www.paho.org/English/AD/FCH/IM/TAG17-2006-FinalReport-Eng. pdf. Accessed 11 August 2009.
22. Suárez-Ognio L, Adrianzén A, Ortiz A, et al. A rubella serosurvey in postpartum women in the three regions of Peru. Rev Panam Salud Publica 2007; 22:110-7. (Pubitemid 350171865)
23. Pan American Health Organization. Measles/rubella weekly bulletin for week ending 8 March 2008. http://www.paho.org/English/AD/FCH/IM/sme1410.pdf. Accessed 11 August 2009.
24. Donadio FF, Siquiera MM, Vyse A, Jin L, Oliveira SA. The genomic analysis of rubella virus detected from outbreak and sporadic cases in Rio de Janeiro state, Brazil. J Clin Virol 2003; 27:205-9. (Pubitemid 37329342)
25. Lanzieri TM, Segatto TC, Siqueira MM, de Oliviera Santos EC, Jin L, Prevots DR. Burden of congenital rubella syndrome after a communitywide rubella outbreak, Rio Branco, Acre, Brazil, 2000 to 2001. Pediatr Infect Dis J 2003; 22:323-9. (Pubitemid 36461033)
26. Reef SE, Redd SB, Abernathy E, Kutty P, Icenogle J. Evidence used to support the achievement and maintenance of elimination of rubella and congenital rubella syndrome in the United States. J Infect Dis 2011; 204(Suppl 2):S593-7.
27. Macey J, Lipskie T, Tam T, Tipples G, Eisbrenner T. Rubella elimination, the Canadian experience. J Infect Dis 2011; 204(Suppl 2):S585-92.
28. Hahné S, Macey J, van Binnendijk R, et al. Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada. Pediatr Infect Dis J 2009; 28:795-800.
29. World Health Organization (WHO). WHO vaccine-preventable diseases: monitoring system, 2008. global summary. http://www.who.int/immunization/ documents/WHO-IVB-2008/en/index.html. Accessed 19 November 2009.
30. Pan American Health Organization. Rubella watch, July 2007. http://www.paho.org/English/AD/FCH/IM/NL-RubellaWatch2007-04.pdf. Accessed 11 August 2009.
31. Pan American Health Organization. Measles/Rubella weekly bulletin for week ending 5 Jan 2008. http://www.paho.org/English/AD/FCH/IM/sme1401.pdf. Accessed 11 August 2009.
32. Pan American Health Organization. Measles/Rubella weekly bulletin for week ending 11 April 2009. http://www.paho.org/English/AD/FCH/IM/sme1514.pdf. Accessed 11 August 2009.
33. Centers for Disease Control and Prevention. Brief report: imported case of congenital rubella syndrome-New Hampshire, 2005. Morb Mortal Wkly Rep 2005; 54:1160-1.
34. Best JM, O'Shea S. Rubella virus. In: Lennette EH, Lennette DA, Lennette ET eds. Diagnostic procedures for viral, Rickettsial, and Chlamydial infections. Washington, DC: American Public Health Association, 1995; 583-600.
35. Abernathy ES, Hubschen JM, Muller CP, et al. Status of global virologic surveillance for rubella viruses. J Infect Dis 2011; 204(Suppl 1):S524-32.